Overview (18 Sep 2026)
Senores Pharmaceuticals Ltd
SENORES
INE0RB801010

Pharmaceuticals
Result was last declared on 14 May 2026
0

Prev. Close
Previous Close
1402.6
Current Close
1402.6
Current High
1441.9
Current Low
1391.7
52 Week High
1599
52 Week Low
661.65
Resistance 1
1432.44
Resistance 2
1462.27
Support 1
1382.24
Support 2
1332.04
Std Deviation
4.27%
DMA 200
1041.31
DMA 50
1433.49
DMA 20
1461.00
Fundamentals and Ratios
Standalone
Trailing EPS
4.4
Forwad EPS
5.39
Trailing P/E
318.77
Forward P/E
260.38
PEG Ratio
-40.48
Mkt. Cap (Cr)
Market Cap (Cr)
6459.48
Total Debt(Cr)
Tot. Debt(Cr)
327.09
Reserve (Cr)
887.55
Book Value
199.49
P/BV Ratio
7.03
ROCE(%)
3.00
ROE
4.00
Consolidated
Trailing EPS
26.39
Forwad EPS
29.15
Trailing P/E
53.15
Forward P/E
48.12
PEG Ratio
6.48
Mkt. Cap (Cr)
Market Cap (Cr)
6459.48
Total Debt(Cr)
Tot. Debt(Cr)
342.03
Reserve (Cr)
887.55
Book Value
202.52
P/BV Ratio
6.93
ROCE(%)
15.62
ROE
14.0100

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue26.9936.8128.7635.3319.82106.09
Other Income9.5522.199.7811.368.3966.35
Total Income36.5459.0038.5446.6928.21172.44
Interest2.221.891.751.581.766.98
Expenditure-35.15-46.31-35.02-39.04-24.62-144.98
PBDT0.000.000.000.000.000.00
Depreciation-3.61-4.13-3.58-3.65-1.88-13.23
PBT1.3912.693.527.653.5927.46
Tax-0.36-4.21-0.87-1.22-0.89-7.21
Equity46.0546.050.000.0046.0546.05
OPM3.8021.5112.2421.6512.7315.92
Net Profit1.038.482.656.432.720.25
NPM2.8214.379.2118.29.5711.74
EPS0.221.841.981.40.594.4
Consolidated
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue180.21175.19174.56161.76137.99632.63
Other Income2.8117.673.785.413.3647.06
Total Income183.02192.86178.34167.17141.35679.69
Interest7.178.465.336.195.0425.03
Expenditure-143.56-145.46-133.74-126.53-114.86-520.59
PBDT0.000.000.000.000.000.00
Depreciation-9.94-9.30-7.85-8.09-6.00-31.25
PBT39.4647.4044.6040.6426.49159.10
Tax-9.01-10.73-11.02-10.52-5.31-37.57
Equity46.0546.050.0046.0546.0546.05
OPM21.5624.5825.0124.3118.7423.41
Net Profit30.4536.6733.5830.1221.18121.53
NPM16.6419.0118.8318.0214.9817.88
EPS6.617.967.296.544.626.39
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings